ICH Project The 18th ICH Public Meeting

August 05, 2008

The 18th ICH Public Meeting was held in Japan which took place at the Kudan Hall, Meguro-ku in Tokyo on August 5, 2008.This Public Meeting aimed to provide an opportunity to give the public updated information on the progress made during the ICH Meeting in Portland in June 2008, and on the status of the various ICH Guidelines under development with a follow-up Q & A session.

Working Language
Japanese
Simultaneous English-Japanese Translation
Not Available
Location
Kudan Hall, 1-1, Surugadai, Kanda, Chiyoda-ku, Tokyo, Japan
Date
August 5, 2008

 

Presentation materials Speakers

 

01_ Overview of ICH Topics

Takayuki Okubo, MHLW

Topics for the Electronic Exchange of Information

02_Electronic Standards for the Transfer of Regulatory Information

Yasuhiro Araki, MHLW(PMDA)

Safety Topic

03_M3(R2):Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals

Fumio Sagami, JPMA

Efficacy Topic

04_E2F:Development Safety Update Report

Noriko Akagi, JPMA

05_E14 IWG Q&A: Questions & Answers: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Maki Ito, JPMA

06_E16:Biomarkers Related to Drugs or Biotechnology Product Development: Context, Structure and Format of Qualification Submissions

Akihiro Ishiguro,
MHLW(PMDA)

Quality Topics

07_Q10:Pharmaceutical Quality System

Tetsu Yamada, JPMA

08_Q11:Development and Manufacture of Drug Substances(Chemical Entities and Biotechnological/Biological Entities)

Yoshihiro Matsuda, MHLW(PMDA)

share